baber/WOPTO huggingface dataset:
Patent AU-5503594-A (AU)
Title: Fuel burner apparatus and method employing divergent flow nozzle
Inventor: YAP LOO T
IPC: F23D14/56
Filed: 1994-02-09
Abstract: The burner comprises a fuel nozzle for producing a fuel jet of outwardly divergent, fan-shaped configuration. The fuel jet is adapted to burn within the oxidant with an outwardly extending and divergent flame. There is upper and lower oxidant nozzle separate and distinct from one another and from the fuel nozzle for producing upper and lower oxidant jets of outwardly divergent, fan-shaped configuration located above and below the fuel jet, respectively, and having a lower velocity than the fuel jet such that the oxidant is aspirated into the oxidant.
Patent AU-5659499-A (AU)
Title: Method for preparing a H2-rich gas and a CO2-rich gas at high pressure
Inventor: OLSVIK OLA
IPC: C01B32/50
Filed: 1999-09-15
Abstract: The present invention concerns a method for preparing a CO<SUB>2</SUB>-rich gas stream for injection purposes or deposition, and a hydrogen rich gas stream, the method comprising the following steps: a) natural gas and H<SUB>2</SUB>O are fed into a one-step reforming process for preparing a gas mixture comprising CO<SUB>2 </SUB>and H<SUB>2 </SUB>under supercritical condition for water from about 400° C. to about 600° C. and pressure from about 200 to about 500 bar in the reforming reactor; b) the gas mixture from a) is separated into a H<SUB>2</SUB>-rich and CO<SUB>2</SUB>-rich gas stream, respectively. The invention also comprises use of CO<SUB>2</SUB>-rich gas stream for injection into marine formations, and use of H<SUB>2</SUB>-rich stream for hydrogenation, as a source of energy/fuel in fuel cells and for production or electricity.
Patent AU-5860496-A (AU)
Title: System for controlling the temperature of a temperature cont rol fluid in an internal combustion engine
Inventor: HOLLIS THOMAS J
IPC: F01P7/14
Filed: 1996-05-16
Abstract: A temperature control system in an internal combustion engine includes a heating arrangement which channels a flow of temperature control fluid from an engine to and from an exhaust heating assembly (142) which is located adjacent to an exhaust manifold (140) in the engine. The exhaust heat assembly (142) permits the transfer of heat from the exhaust gases flowing in the exhaust manifold (140) to the temperature control fluid. The heated temperature control fluid is then directed back to the engine for efficient heating. In one embodiment, the temperature control fluid is directed through a heat exchanger in the engine oil pan (28) so as to maintain the temperature of the engine lubricating oil at or near its optimum operating temperature. In a second embodiment, the temperature control fluid is directed from the exhaust heat assembly to the intake manifold (130) so as to increase the temperature of the intake air prior to combustion.
Patent AU-5931599-A (AU)
Title: Preparation of sulphuryl fluoride
Inventor: SCHULZ ALF
IPC: C01B17/45
Filed: 1999-11-10
Abstract: Sulfuryl fluoride is prepared selectively and in a high yield from sulfur dioxide and elemental fluorine in the presence of an alkali fluoride and hydrogen fluoride. The preferred alkali fluoride is potassium fluoride.
Patent AU-5982799-A (AU)
Title: Carriage for conveying motor vehicles in multistorey carparks
Inventor: MANZOTTI CARLO
IPC: E04H6/18
Filed: 1999-10-04
Abstract: A carriage (4) for conveying vehicles in multistorey carparks comprises a front module (7) and rear module (7') which are separable, provided with independant motor systems and can operate on the front (52) and rear wheels (55), respectively, of a vehicle (50) so as to be able to lift it and transport it from a platform (1) of a translator elevator (100) to a floor (101) of stalls or of the entrance-exit room of a multistorey car park and vice versa.
Patent AU-6223100-A (AU)
Title: Method and apparatus for sequentially synchronized network
Inventor: SOLIMAN SAMIR S
IPC: H04W84/04
Filed: 2000-07-19
Abstract: A method and apparatus for sequentially synchronized timing and frequency generation in a communication network includes a parent station for maintaining system time and frequency values, a time/frequency transfer unit for receiving and demodulating the system time and frequency values from the parent station and generating corrected system time and frequency values by adjusting a clock and the center frequency of a pilot signal at a child station to remove time and frequency discrepancies, and a child station to which the time/frequency transfer unit directly communicates the corrected system time and frequency values. The child station become a parent station upon communication of the corrected system time and frequency values. The sequence may be repeated for as many stations as are deployed in the network.
Patent AU-6302594-A (AU)
Title: Novel N-alkylacridan carboxyl derivatives useful for chemiluminescent detection
Inventor: AKHAVAN-TAFTI M HASHEM
IPC: C07D219/02
Filed: 1994-05-12
Abstract: N-alkylacridan carboxylic acid derivative compounds (I) are used to generate chemiluminescence by the action of a peroxidase enzyme and an oxidant. The compounds I are useful in assays of all types. <IMAGE>
Patent AU-6390298-A (AU)
Title: Omega-amino acid derivatives, processes of their preparation and their use
Inventor: HRABALEK ALEXANDR
IPC: C07C229/06
Filed: 1998-04-01
Abstract: The invention relates to amino acid derivatives of general formula (I), wherein R1 is H or CH3, X is H or NR2R3, wherein R2 is H, CH3, COH or COCH3 and R3 is H, CH3 or COO-Z wherein Z is R2R3 NH+CHR1(CH2)nCOO(CH2)mCH2Y; Y is H, CH3 or NHR4, wherein R4 a COO-NH3+CH2(CH2)mOOC(CH2)nCH3, the meaning of group (CH2)m being selected from alkyls, secondary alkyls, monocycloalkyls, bicycloalkyls and tricycloalkyls having from 4 to 15 carbon atoms and n having a value of from 3 to 14. omega-Amino acid derivatives of the invention are prepared by reacting a primary or secondary or monocyclic or bicyclic or tricyclic alcohol with the reaction product of an amino acid or an N-substituted amino acid with thionyl chloride, whereafter the amino group, which has been released by an amine, reacts with carbon dioxide providing a derivative of carbamic acid, or by directly reacting a primary or secondary or monocyclic or bicyclic or tricyclic alcohol with an N-substituted amino acid in the presence of a condensing agent giving the corresponding ester of the N-substituted amino acid. Thus produced compounds of formula (I) can be used as transdermal penetration enhancers. Incorporation of from 0.1 w/w percent to 5.0 w/w percent of a compound of the invention as a transdermal penetration enhancer in the vehicle of a topically applied pharmaceutical or cosmetic composition enhances transdermal penetration of pharmaceutical agents through the human or animal skin. Included further are transdermal penetration enhancers consisting of at least one compound of formula (I).
Patent AU-6432200-A (AU)
Title: Method for producing modified polycarbonates
Inventor: KRATSCHMER SILKE
IPC: C08J5/18
Filed: 2000-07-06
Abstract: A process for the synthesis of polycarbonate is disclosed. The process entails reacting in the presence of at least one phosphonium salt as catalyst, at least one diphenol, at least one carbonic acid diester, and at least one alkyl group-substituted phenol chain terminator. The chain terminator is introduced in free form or as a transesterifiable compound under the conditions of the synthesis. The polycarbonate thus produced is suitable for preparing a variety of molded articles.
Patent AU-6483496-A (AU)
Title: Analogs of parathyroid hormone
Inventor: DONG ZHENG XIN
IPC: C07K1/06
Filed: 1996-07-03
Abstract: Peptide variants of fragment (1-34) of parathyroid hormone, in which at least one of the amino acid residues at positions 7, 11, 23, 24, 27, 28 and 31 is cyclohexylalanine, or at least one of the amino acid residues at positions 3, 16, 17, 18, 19 and 34 is  alpha -aminoisobutyric acid; or, alternatively, at least the amino acid residue at position 1 is  alpha , beta -diaminopropionic acid, the amino acid residue at position 27 is homoarginine, or the amino acid residue at position 31 is norleucine.
Patent AU-6516594-A (AU)
Title: Telemetry arrangement
Inventor: GARLAND STUART MANDEL
IPC: H04Q9/00
Filed: 1994-02-16
Abstract: A communication switching system, in addition to normal services i.e., voice, FAX, data, etc., provides secure bi-directional communication between the facilities of a utility and specialized voice and/or data CPE which are served by an on-premises Telemetry Interface Unit. A Central Office Service Unit (COSU), which is connected to a switching system by Utility Telemetry Trunks (UTT), is employed as an interface between utilities and one or more communication switching systems. The COSU provides detailed calling instructions and data which define the services to be rendered by the switching system. The detailed instructions serve to: define the source and character of the signals to be used to alert the TIU; sub-addresses of CPE served by a TIU; conduct of line supervision; permitted supervisory state of a called line at time of call to a TIU; broadcast of messages, etc.
Patent AU-6613096-A (AU)
Title: Method for tracing payment data in an anonymous payment system, as well as payment system in which the method is applied
Inventor: ROOIJ PETER JACOBUS NICOLAAS D
IPC: G07F7/08
Filed: 1996-07-05
Abstract: The invention relates to a method for tracing payment data in an anonymous payment system having electronic payment means, such as so-called "smart cards". According to the invention, the user commits himself to a value (w) which may later be used for the tracing by a payment institution. The value (w) is preferably recorded with the help of a so-called one-way function (F) and an (electronic) signature ( sigma ), so that the payment institution does not dispose of the value itself, but is able to verify it on the basis of the stored derivative (w'') of the value. The invention further relates to a payment means and a payment system for application of the method.
Patent AU-6650200-A (AU)
Title: New polycyclic azaindole compounds, a process for their preparation and pharmaceutical compositins containing them
Inventor: GUILLAUMET GERALD
IPC: C07D471/14
Filed: 2000-10-13
Abstract: Polycyclic azoindoline derivatives (I), their enantiomers, diastereoisomers, and salts with acids and bases, their preparation, intermediates for their preparation, and pharmaceutical compositions containing them are new. Polycyclic azoindoline derivatives of formula (I) in which the dotted line indicates an optional unsaturation, and the group of formula (a) = a group (b), (c), (d) or (e); R<1> = halogen, -R, -OR, -S(O)nR, -NRR', -NR-CZ-R', -NR-CZ-OR', -NR-CZ-NR'R, -NR-SO2-R', -CZ-NR'R, or -SO2-NR'R; n = 0, 1 or 2; Z = S or O; R, R', and R = H, 1-6C alkyl, 2-6C alkenyl or alkynyl, all of which may be substituted, 3-8C cycloalkyl optionally substituted, cycloalkyl alkyl optionally substituted, aralkyl, heteroaryl, heteroaryl alkyl, or R' may form, with R or R and the N atom to which they are attached, a morpholino, piperidinyl, piperazinyl, or pyrrolidinyl group which may be substituted; G1 = 1-4C alkylene that may be substituted by R, OR, -COR, or -COOR, or it is a 1-4C alkylene chain in which one of the methylene groups is replaced by 3-8C cycloalkylene; A = - -CZ-NRR', -NR-CZ-R', or -NR-CZ-NR'R; B' forms with the N atom and the C atom to which it is attached = a 5-8 membered chain that may be saturated or unsaturated and may contain a further O, N, or S heteroatom; R<2> and R<3> = H, 1-6C alkyl or alkoxy, or OH, or together they form an oxo group; R<4> and R<5> = H or together with two adjacent C atoms on ring B form an aryl or heteroaryl group. The optional substituents on alkyl, alkenyl, alkynyl, cycloalkyl morpholinyl, piperidinyl, piperazinyl and pyrrolidinyl groups may be OH, oxo, alkoxy, alkyl, polyhaloalkyl, or halogen. The optional substituents on cycloalkylalkyl groups may be one or more OH, oxo, alkoxy, alkyl, polyhaloalkyl, or halogen groups on the cyclic group. The term aryl covers phenyl, naphthyl, or biphenyl, these being optionally substituted by one or more OH, alkoxy, alkyl, amino, mono- or di-alkylamino, nitro, cyano, polyhaloalkyl, formyl, carboxy, alkoxycarbonyl, amido or halogens. The term heteroaryl covers furyl, pyrrolyl, imidazolyl, pyridyl, thienyl, pyrazinyl, benzothienyl, benzofuranyl, indolyl, benzimidazolyl, quinolyl, or quinazolinyl, these being optionally substituted by one or more OH, alkoxy, alkyl, amino, mono- or di-alkylamino, nitro, cyano, polyhaloalkyl, formyl, carboxy, amido or halogens. An Independent claim is included for intermediates of formula (XVII).
Patent AU-6763598-A (AU)
Title: Death domain containing receptor 5
Inventor: NI JIAN
IPC: A61P25/28
Filed: 1998-03-17
Abstract: The present invention relates to novel Death Domain Containing Receptor-5 (DR5) proteins which are members of the tumor necrosis factor (TNF) receptor family, and have now been shown to bind TRAIL. In particular, isolated nucleic acid molecules are provided encoding the human DR5 proteins. DR5 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying antagonists and antagonists of DR5 activity.
Patent AU-6776300-A (AU)
Title: Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases
Inventor: KOPPEL GARY A
IPC: A61K45/06
Filed: 2000-08-16
Abstract: A ²-lactam compound selected from: 
i) clavulanic acid or a pharmaceutically acceptable salt thereof or an active ester form thereof; or 
ii) moxalactam or a pharmaceutically acceptable salt thereof or an active ester form thereof, 
for use in the treatment of a patient in need of relief from a sexual disorder, and for use in the treatment of prostate cancer or benign prostatic hyperplasia.
Patent AU-6834894-A (AU)
Title: Assay for cardiac troponin i
Inventor: WICKS RICHARD W
IPC: C07K17/00
Filed: 1994-05-16
Abstract: A method for detection of cardiac troponin I is described. The method is a sandwich assay employing an antibody specific for cardiac troponin I as one binding partner and troponin C as the other binding partner for cardiac troponin I.
Patent AU-6922800-A (AU)
Title: Dna encoding the human serine protease eos
Inventor: DARROW ANDREW L
IPC: C12N1/15
Filed: 2000-08-18
Abstract: Here we describe the molecular identification of a cDNA encoding a novel serine protease we have termed protease EOS. The deduced amino acid sequence, and it alignment with other well-characterized serine proteases indicates that it is a member of the S1 serine protease family. We have found that the protease EOS mRNA is expressed in platelets and leukocytes and more specifically eosinophils. Although this protease is abundantly expressed in ovary, retina and stomach, where it may perform important functions, its expression in platelets and certain cells of the immune system suggests that it may play roles in thrombosis and in the immune process. Enzymatically active protease EOS is amenable to further biochemical analyses for the identification of physiological substrates and specific modulators
Patent AU-7002087-A (AU)
Title: Method and apparatus for producing honeycomb material
Inventor: SCHNEBLY JOHN T
IPC: E06B9/13
Filed: 1987-03-13
Abstract: A process and apparatus for fabricating expandable honeycomb materials (172) are disclosed. Adhesive is first applied along the length of a continuous material (14) by first heating the material (14), applying the adhesive (18) in a liquid state to the heated material (14), and then cooling the material (14) to solidify the adhesive. The continuous length of material (14) is folded along opposite side portions thereof into a generally flat tubular form having upper and lower layers. The folded tubular material (74) with solidified adhesive lines thereon is then wound about a rack (120) in such a manner that the tubular material (74) is deposited in a plurality of continuous layers one on another with the lines of adhesive (18) being disposed between adjacent layers. The wound layers (74) are then radially cut (122) and placed in a vertically aligned stack while they are removed from the rack (120). The vertically stacked layers are then heated to a temperature sufficient to activate the lines of adhesive (18) and bond the layers together. Finally, the stacked tubular material is cooled to form a unitary stack of tubular, expandable honeycomb material (172). A device for performing the process as described above is also disclosed.
Patent AU-7048901-A (AU)
Title: Edg8 receptor, its preparation and use
Inventor: KOSTENIS EVI
IPC: C07K14/705
Filed: 2001-04-14
Abstract: The present invention relates to newly identified human EDG8 receptors, polynucleotides encoding this receptor, polypeptides encoded by such polynucleotides, the preparation and the use of such polynucleotides and polypeptides.
Patent AU-7052487-A (AU)
Title: Primary transmission line cable
Inventor: HUBIS PAUL EVERETT
IPC: H01B11/12
Filed: 1987-03-23
Abstract: An electrical transmission wire consisting of a single or a twisted pair of wires has the effective electrical diameter of the primary conductor increased by wrapping conductive foil (2), or conductive foil (2) laminated to a substrate layer (1), on to a primary conductor (3) with a diameter less than 20 mils (0.508mm), the foil being in contact with the conductor. An outer insulating cover (4) may be applied over the wrapped wire. The conductive wrapping can be a spiral wrapping or a longitudinal wrapping around the electrical conductor. A desired characteristic impedance along the length of the wire(s) can be achieved with easy removal of the wire covering for standard termination and increased cut-through resistance.
Patent AU-7071394-A (AU)
Title: Low fat spread
Inventor: NORTON IAN TIMOTHY
IPC: A23L29/231
Filed: 1994-06-07
Abstract: A fat-continuous spread comprising: (A) from 0.1 to 10 wt % of gelatin; (B) from 0.1 to 7 wt % of a gelled polysaccharide not being starch; and (C) from 10 to 60 wt % of fat. The balance of the above being traditional constituents of spreads.
Patent AU-7227391-A (AU)
Title: Coated media for chromatography
Inventor: VARADY LASZLO
IPC: B01D15/08
Filed: 1991-01-16
Abstract: Disclosed are pellicular materials useful in contact with proteins and as chromatography media. Rigid, inert, hydrophobic, polymeric materials are exposed to a solution comprising a solute defining plural interspersed hydrophobic and hydrophilic domains. The solute molecules adsorb onto the surface of the substrate by hydrophobic - hydrophobic interaction with their hydrophilic domains extending outwardly away from the surface into the solution. The molecules are then crosslinked in place to produce a solvent and pH resistant coating which presents a hydrophilic surface sufficient to mask hydrophobic regions therebeneath. The multidomain adsorbing compounds may comprise reactive groups which subsequently can be derivatized using conventional techniques to produce chromatography materials useful for conducting affinity, size exclusion, cationic exchange, anionic exchange, neutral hydrophobic interaction, and other forms of chromatographic separations.
Patent AU-7300191-A (AU)
Title: Co-independent growth medium for maintenance and propagation of cells
Inventor: VISTICA DAVID THOMAS
IPC: C12N5/07
Filed: 1991-01-22
Abstract: For the propagation or maintenance of cells in vitro, a culture medium which does not require CO2 in excess of the concentration found in ambient air is described. The medium contains the free base forms of L-arginine, L-cysteine, L-histidine, L-lysine and L-tyrosine; biotin; fatty acids; pyruvate; asparagine; low levels of sodium bicarbonate and is buffered with  beta -glycerophosphate. Te use of the medium to culture tumor cells to test anti-tumor compounds is also disclosed.
Patent AU-7407496-A (AU)
Title: Fibered micro vaso-occlusive devices
Inventor: SEPETKA IVAN
IPC: A61B19/00
Filed: 1996-11-29
Abstract: This is a micro-vaso-occlusive device 100 intended generally for occlusion of small arteries located distally in the vasculature. The invention is made up of a binder portion 102, often radio-opaque, which is short in length in comparison to the length of the included thrombogenic fibers 104. The fibers 104 form the other portion of the device. The micro device may have multiple binder sections 128. The fibers 104 may be straight, looped, or tufted. <IMAGE>
Patent AU-7409700-A (AU)
Title: Brake system for vehicles, especially commercial vehicles
Inventor: MAYR-FROHLICH MATHIAS
IPC: B60T8/1761
Filed: 2000-08-17
Abstract: The invention relates to a pneumatic-hydraulic brake system with a pneumatic/hydraulic converter which converts a pressure that is pneumatically input by the driver into a hydraulic brake pressure. A sensor is provided which detects a physical variable that gets adjusted in the converter when the pneumatic pressure is input. The sensor generates a warning signal when a pre-given variable is detected.
Patent AU-7485400-A (AU)
Title: Toilet bowl cleaning method
Inventor: KLINKHAMMER MICHAEL E
IPC: C11D1/83
Filed: 2000-09-14
Abstract: Disclosed herein are methods of cleaning toilet basins and urinals. Cleaning components are applied to the interior surfaces of these basins other than through the flush water, without scrubbing. They are allowed to be in contact with the surface of the basin for at least one-half hour before normal use of the toilet/urinal. Preferred methods for applying the cleaning compositions are with a spray bottle or an aerosol can, with application occurring on a daily, overnight basis.
Patent AU-7634400-A (AU)
Title: Isolation of precursor cells and their use for tissue repair
Inventor: LUYTEN FRANK
IPC: A61K35/12
Filed: 2000-10-06
Abstract: Positively identifying viable precursor cells that have entered a post-natal differentiation pathway comprises using reagents, ligands and/or antibodies to recognize an embryonic cell surface marker such as an expressed morphogenic protein, its homolog or a marker co-expressed and/or co-detectable with this marker, so as to sort and enrich the precursor cells. Independent claims are also included for: (1) producing or repairing connective tissue in a mammal by using skeletal precursor cells (I), marked with an expressed morphogenic protein, its homologs or co-expressed and/or co-detectable markers e.g. FGFR3 (fibroblast growth factor receptor 3), a gene, protein or mRNA expressed in the precursor cells; (2) using (I) as a source of growth factors; (3) a culture of viable precursor cells (II) that have entered a specific post-natal differentiation pathway and which express an embryonic marker which is an expressed morphogenic protein, its homolog or a marker co-expressed and/or co-detectable with this marker; (4) an implant (III) comprising (II), especially skeletal precursor cells; and (5) a diagnostic for identifying a positive marker of (II).
Patent AU-8102291-A (AU)
Title: Biologically safe plant transformation system
Inventor: YODER JOHN T
IPC: C12Q1/68
Filed: 1991-07-01
Abstract: This invention relates to methods for producing transgenic plants that contain a gene of interest and that are free of foreign ancillary nucleic acids. These methods allow for the production of plants which thus contain a desired gene, but which are free of vector sequences and/or marker sequences used to transform the plant. The method of transforming such plants calls for transforming the plants with a gene of interest by introduction of the gene on a DNA construct comprising a transposon and foreign ancillary nucleic acids; crossing the transformed plant through self-crossing or with another plant to obtain F1 or more removed generation progeny; and utilizing a means for selecting those progeny that carry the gene of interest and are free of the ancillary nucleic acids. Such progeny may be detected biochemically, by Southern hybridization, through the use of polymerase chain reaction procedures and other methods available in the art.